Discontinuation report ACT OLANZAPINE ODT

Last updated on 2019-10-26 History
Report ID 97256
Drug Identification Number 02327562
Brand name ACT OLANZAPINE ODT
Common or Proper name OLANZAPINE 5MG ODT
Company Name TEVA CANADA LIMITED
Active Ingredient(s) OLANZAPINE
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 30
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-10-25
Remaining supply date 2019-10-25
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-10-26 English Compare
v2 2019-10-25 French Compare
v1 2019-10-25 English Compare